BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 23349312)

  • 1. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy.
    Savige J; Gregory M; Gross O; Kashtan C; Ding J; Flinter F
    J Am Soc Nephrol; 2013 Feb; 24(3):364-75. PubMed ID: 23349312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
    Savige J
    Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alport Syndrome in Women and Girls.
    Savige J; Colville D; Rheault M; Gear S; Lennon R; Lagas S; Finlay M; Flinter F
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1713-1720. PubMed ID: 27287265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
    Zhang Y; Ding J
    Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport Syndrome: Achieving Early Diagnosis and Treatment.
    Kashtan CE
    Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal retinal thinning and the diagnosis of Alport syndrome and Thin basement membrane nephropathy.
    Chen Y; Colville D; Ierino F; Symons A; Savige J
    Ophthalmic Genet; 2018 Apr; 39(2):208-214. PubMed ID: 29172845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis.
    Haas M
    Arch Pathol Lab Med; 2009 Feb; 133(2):224-32. PubMed ID: 19195966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome.
    Buzza M; Wilson D; Savige J
    Kidney Int; 2001 May; 59(5):1670-6. PubMed ID: 11318937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alport syndrome and thin basement membrane nephropathy.
    Thorner PS
    Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.
    Buzza M; Wang YY; Dagher H; Babon JJ; Cotton RG; Powell H; Dowling J; Savige J
    Kidney Int; 2001 Aug; 60(2):480-3. PubMed ID: 11473630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of collagen type IV nephropathies: from thin basement membrane nephropathy to Alport syndrome.
    Vizjak A; Ferluga D
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():323-6. PubMed ID: 20804103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.
    Temme J; Peters F; Lange K; Pirson Y; Heidet L; Torra R; Grunfeld JP; Weber M; Licht C; Müller GA; Gross O
    Kidney Int; 2012 Apr; 81(8):779-83. PubMed ID: 22237748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020.
    Kashtan CE; Gross O
    Pediatr Nephrol; 2021 Mar; 36(3):711-719. PubMed ID: 33159213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic features in autosomal recessive and X-linked Alport syndrome.
    Wang Y; Sivakumar V; Mohammad M; Colville D; Storey H; Flinter F; Dagher H; Savige J
    Pediatr Nephrol; 2014 Mar; 29(3):391-6. PubMed ID: 24178893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased microvascular disease in X-linked and autosomal recessive Alport syndrome: a case control cross sectional observational study.
    Smith JD; Colville D; Lyttle N; Lamoureux E; Savige J
    Ophthalmic Genet; 2019 Apr; 40(2):129-134. PubMed ID: 30985254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.